Flibanserin (BIMT-17; BIMT-17BS; EBD-6396; Girosa; trade name Addyi) is a novel and potent agonist of the 5-HT1A and serotonergic antidepressant approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD).

AVN-322 (AVN322; AVN 322) is a novel and potent 5-hydroxytryptamine subtype 6 receptor (5-HT6) antagonist with the potential for the treatment of AD (Alzheimer’s disease).

Jatrorrhizine Chloride is a novel and potent AChE inhibitor.

Dolasetron mesylate (MDL-73147) is a potent serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

Lvguidingan, formerly known as Anticonvulsant 7903, is a potent anticonvulsant agent.